Trelagliptin (SYR-472, SYR472, SYR 472) CAS 865759-25-7

We are specialized in offering high purity Trelagliptin(SYR-472) CAS 865759-25-7. Trelagliptin CAS NO 865759-25-7 is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor which is widely used to treatment for type 2 diabetes (T2D). The Trelagliptin 865759-25-7 have commercialization productive kilogram grade each month. We keep certain inventory. We are capable of meeting customers bulk requirement in limited time.

Thera. Category: Anti-Diabetes

Cas No.: 865759-25-7

Synonym: Trelagliptin API; Trelagliptin;1-(2-broMo-5-fluorobenzyl)-6-chloro-3-MethylpriMidine-2,4(1H, 3H)-dione;Trelagliplin;(R)-2-[[6-(3-AMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl]Methyl]-4-fluorobenzonitrile;Trelagliptin(syr472);Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H) -pyrimidinyl]methyl]-4-fluoro-;Trelagliptin (R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile;(S)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile

Molecular Formula: C18H20FN5O2

Molecular Weight: 357.3821032

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:Trelagliptin Succinate controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones* that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels.

Related Products:

6-Chloro-3-methyluracil CAS 4318-56-3

Trelagliptin Succinate DPP-4 inhibitor CAS 1029877-94-8

Trelagliptin (SYR-472, SYR472, SYR 472) CAS 865759-25-7

Product Categories : Inhibitors > DPP-4 Inhibitors